Awardee 2022

Razieh Kebriaei, Michigan, United States

Dr. Kebriaei studied biotechnology engineering in Iran. Then she completed her PhD in biomedical engineering at Wayne State University (USA) in 2016. To combine her background education on the bench with bedside needs, she did a fellowship in infectious diseases at Appelbaum college of pharmacy at WSU. During this fellowship she obtained additional training in clinical microbiology, pharmacokinetic/pharmacodynamic (PK/PD) modeling and infectious diseases. In continuation of this fellowship, she is currently working on multiple projects focused on design and development of in vitro PK/PD models for understanding various infectious disease scenarios including medical device infections, catheter-associated blood stream infections, infective endocarditis, and bacteremia. Her research interests include, novel antibacterial agents including bacteriophages, lysins and novel formulations of antibiotics, resistance prevention in multi-drug resistant clinical isolates, infectious disease modeling using in vitro set-ups and various microbiological assays for understanding the mechanistic theories leading to bacterial resistance.


Awardee 2021

Cihan Papan, Hamburg, Germany

Dr Cihan Papan studied medicine in Innsbruck (Austria) and Paris (France) and graduated in 2010. He completed his specialization in paediatrics at Hauner Children’s Hospital in Munich (Germany) in 2016, after which he did a fellowship in paediatric infectious diseases at Children’s Hospital Mannheim, Heidelberg University (Germany).
Currently, Dr Papan is pursuing his training in clinical microbiology at Saarland University (Germany). He serves as a member to the Committee for Education in the European Society for Paediatric Infectious Diseases (ESPID). As a member of ESGAP and the ESCMID Guidelines Evidence Review Group, Dr Papan is actively involved in guideline development for ESCMID. His research interests include host biomarkers and their clinical utility in differentiating bacterial from viral infections, whole-genome sequencing-based pathogen diagnostics, and conducting and assessing antimicrobial stewardship interventions in various healthcare settings.